Topics

Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug-resistance and virological failure in children.

07:00 EST 29th January 2019 | BioPortfolio

Summary of "Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug-resistance and virological failure in children."

Using cell-associated DNA and cell-free RNA of HIV-1, we investigated the role of drug-resistant viral variants that emerged during early antiretroviral therapy (ART) in determining virological outcome. This case-control study compared virologic non-responder children (two viral loads ≥200 copies/ml within two years of ART) and responder children (two VLs <200 copies/ml after six months of ART) infected with HIV-1 initiated on non-nucleoside reverse transcriptase inhibitor (NNRTI)-based ART. The partial reverse transcriptase gene of HIV-1 in cell-associated DNA was genotyped using next-generation sequencing (NGS; Illumina; threshold 0.5%; at baseline and month six of ART) and in cell-free RNA (concurrently and at virological failure; VL >1000 copies/ml at ≥12 months of ART) using the Sanger method. Among 30 non-responders and 37 responders, baseline differences were insignificant while adherence, viral load and drug resistance mutations (DRMs) observed at month six differed significantly (p=>0.05). At month six, NGS estimated a higher number of DRMs compared to Sanger (50% vs. 33%; p=0.001). Among the non-responders carrying a resistant virus (86.6%) at virological failure, 26% harboured clinically-relevant low-frequency DRMs in the cell-associated DNA at month six (0.5 to 20%; K103N, G190A, Y181C, and M184I). Plasma VL of >3 log copies/ml (AOR=30.4, 95%CI=3.3-281, p=0.003) and treatment-relevant DRMs detected in the cell-associated DNA at month six (AOR=24.2, 95%CI=2.6-221, p=0.005) were independently associated with increased risk for early virological failure. Our findings suggest that treatment-relevant DRMs acquired in cell-associated DNA during the first six months of ART can predict virological failure in children initiated on NNRTI-based ART. This article is protected by copyright. All rights reserved.

Affiliation

Journal Details

This article was published in the following journal.

Name: Journal of medical virology
ISSN: 1096-9071
Pages:

Links

DeepDyve research library

PubMed Articles [36761 Associated PubMed Articles listed on BioPortfolio]

Viral Hepatitis: When to be Considered in Clinical Routine?

Chronic viral hepatitis can remain unrecognized but may nevertheless lead to liver cirrhosis and hepatocellular carcinoma. Thus, patients with elevated liver enzymes as well as risk groups need to be ...

Application of deep sequencing methods for inferring viral population diversity.

The first deep sequencing method was announced in 2005. Due to an increasing number of sequencing data and a reduction in the costs of each sequencing dataset, this innovative technique was soon appli...

Evolution-Driven Attenuation of Alphaviruses Highlights Key Glycoprotein Determinants Regulating Viral Infectivity and Dissemination.

Understanding the fundamental mechanisms of arbovirus transmission and pathogenesis is essential to develop strategies for treatment and prevention. We previously took an in vivo evolution-based appr...

Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?

Three-drug combination antiretroviral therapy (ART) became available in 1996, dramatically improving the prognosis of people living with HIV. The clinical benefits of ART are due to the sustained vira...

Parallel molecular evolution and adaptation in viruses.

Parallel molecular evolution is the independent evolution of the same genotype or phenotype from distinct ancestors. The simple genomes and rapid evolution of many viruses mean they are useful model s...

Clinical Trials [16897 Associated Clinical Trials listed on BioPortfolio]

Co-adaptation Between HIV and CD8 Cellular Immunity

Our objective here is to characterize the viral evolution and viral factors determining HIV virulence, the evolution of the HIV reservoir in PBMC and the co-evolution of anti-HIV CD8 T cel...

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

The purpose of this study is to see if adding 1 drug to an anti-HIV drug combination early in treatment against HIV can lower the viral load (amount of HIV in the blood) to a level so low ...

Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients

CCTG 589 is a randomized, open-label, pilot study comparing the efficacy, safety and tolerability of RAL plus LPV/r to EFV plus TDF/FTC in HIV-infected, treatment-naïve subjects. Subjects...

Third Party Anti-Viral Cytotoxic T-Cells

The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely to patients with viral infect...

Artificial Intelligence Analysis of Initial Scan Evolution of Traumatic Brain Injured Patient to Predict Neurological Outcome

We assume that an early iterative automatic CT scan analysis (D0, D1 and D3) by different AI approaches will allow an early differentiation of the tissues evolution after TBI. Our objectiv...

Medical and Biotech [MESH] Definitions

Proteins that are coded by immediate-early genes, in the absence of de novo protein synthesis. The term was originally used exclusively for viral regulatory proteins that were synthesized just after viral integration into the host cell. It is also used to describe cellular proteins which are synthesized immediately after the resting cell is stimulated by extracellular signals.

Genes that show rapid and transient expression in the absence of de novo protein synthesis. The term was originally used exclusively for viral genes where immediate-early referred to transcription immediately following virus integration into the host cell. It is also used to describe cellular genes which are expressed immediately after resting cells are stimulated by extracellular signals such as growth factors and neurotransmitters.

Proteins encoded by adenoviruses that are synthesized prior to, and in the absence of, viral DNA replication. The proteins are involved in both positive and negative regulation of expression in viral and cellular genes, and also affect the stability of viral mRNA. Some are also involved in oncogenic transformation.

Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.

A phylum of primitive invertebrate animals that exemplify a simple body organization. Trichoplax adhaerens is considered a key species for early metazoan evolution.

Quick Search


DeepDyve research library

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Searches Linking to this Article